NuVasive Appoints New Chief Financial Officer and Announces Additional Manageme...( SAN DIEGO Nov. 6 /- NuVasive Inc. (Na...),Health

SAN DIEGO, Nov. 6 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today the appointment of Michael J. Lambert as Executive Vice President and Chief Financial Officer, effective November 9, 2009. The Company also announced several other Executive Management Team updates.

"Michael will be an excellent complement to the NuVasive family," said Alex Lukianov, Chairman and Chief Executive Officer of NuVasive. "He has proven himself to be a strong financial leader, including experience as the Chief Financial Officer of a medical device company with over $1 billion in revenue. Michael's background has afforded him a wealth of experience in information technology and operations, which will be extremely valuable as we evolve into a much larger, yet still dynamic growth company."

Mr. Lambert has been the Chief Financial Officer and held other key financial positions at other public companies. Most recently he was the Chief Financial Officer of Advanced Medical Optics, a medical device company focused on technologies used by eye care professionals. As the financial leader of a global organization, he developed in-depth operational expertise and critical analytical skills.

Mr. Lambert will succeed Kevin O'Boyle, who has served as the Chief Financial Officer of NuVasive since the company went public in 2004. Mr. O'Boyle will actively assist Mr. Lambert's transition into his new role through the end of the year.

NuVasive continues to strategically evolve its organizational structure in anticipation of becoming a worldwide leader in innovative spine surgery. Central to the creation of NuVasive's global infrastructure is a leadership team capable of driving the Company toward its l
'/>"/>